ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 115 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,107,592 | -8.6% | 43,350 | +2.6% | 0.00% | – |
| Q2 2023 | $1,211,788 | +15.3% | 42,252 | -3.7% | 0.00% | – |
| Q1 2023 | $1,051,324 | +41.0% | 43,860 | -0.3% | 0.00% | – |
| Q4 2022 | $745,816 | +13.9% | 43,975 | -0.6% | 0.00% | – |
| Q3 2022 | $655,000 | -26.2% | 44,224 | -21.5% | 0.00% | – |
| Q2 2022 | $887,000 | -41.5% | 56,348 | +0.1% | 0.00% | – |
| Q1 2022 | $1,517,000 | -19.3% | 56,273 | +10.8% | 0.00% | – |
| Q4 2021 | $1,879,000 | – | 50,790 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DFPG INVESTMENTS, LLC | 456,390 | $5,541,000 | 3.62% |
| DAFNA Capital Management LLC | 173,914 | $1,890,000 | 0.65% |
| One68 Global Capital, LLC | 19,861 | $216,000 | 0.47% |
| Diametric Capital, LP | 51,982 | $565,000 | 0.41% |
| ARK Investment Management | 1,383,756 | $15,041,000 | 0.38% |
| EAM Investors, LLC | 52,833 | $574,000 | 0.13% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 31,404 | $341,000 | 0.05% |
| Nikko Asset Management Americas, Inc. | 280,548 | $3,050,000 | 0.05% |
| MGO ONE SEVEN LLC | 14,900 | $161,000 | 0.04% |
| Qube Research & Technologies Ltd | 67,702 | $736,000 | 0.02% |